Concepedia

John Delehanty

JD

Statistics

Publications

10

Citations

1.9K

H-Index

10

Active since

1986

Affiliations

La Roche College(Current)

University of California, San Francisco

Quest Clinical Research (United States)

Burroughs Wellcome Fund

University of Toronto

John Delehanty is an author at La Roche College specializing in antiviral therapy, pharmacology, and antiviral pharmacology.

Publications per year

1986–2003

10

Publications

10

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

Jacob Lalezari, Keith Henry, Mary O’Hearn et al. · New England Journal of Medicine · 2003 · 915 citations · Full text

, , +16

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia

Adriano Lazzarin, Bonaventura Clotet, David A. Cooper et al. · New England Journal of Medicine · 2003 · 653 citations · Full text

, , +14

Dose Range Study of Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults with Hepatitis B Virus Infection

Robert G. Gish, Nancy W.Y. Leung, Teresa L. Wright et al. · Antimicrobial Agents and Chemotherapy · 2002 · 93 citations · Full text

, , +16

A Controlled Phase Ii Trial Assessing Three Doses of Enfuvirtide (T-20) in Combination with Abacavir, Amprenavir, Ritonavir and Efavirenz in Non-Nucleoside Reverse Transcriptase Inhibitor-Naive HIV-Infected Adults

Jacob Lalezari, Edwin DeJesus, Donald W. Northfelt et al. · Antiviral Therapy · 2003 · 79 citations · Full text

, , +17

Effect of topical carteolol on the normal human retinal circulation.

J E Grunwald, John Delehanty · PubMed · 1992 · 41 citations

, , +16

1–5 of 10